Head of Formulation and Analytical
Vaxxas Pty Ltd
Brisbane, Queensland, Australia
Dr Namjoshi has worked in the pharmaceutical industry since 2009 in formulation development, manufacture, characterization, and registration of new dermatology products. She has extensive experience in development of novel active skin delivery platforms and assessment of skin permeation of several actives using formulation approaches, chemical and physical conjugation to enhance delivery. She was a Principal investigator on FDA projects developing a tool kit for in vitro characterization of bioequivalence of topical products. Currently at Vaxxas, she is the head of formulation and analytical responsible for formulation development, analytical method development and validation as well as process development.
Future of Vaccination With Novel Microarray Patch (MAP) Technology
Wednesday, October 25, 2023
9:30 AM – 10:00 AM ET